DRUG · Unmapped registry intervention
Carvedilol CR
Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure
NCT00669279
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Atenolol
Normalized identity: atenololView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hypertensionunresolved
Interventions
Carvedilol CRDRUG
AtenololDRUG · verified · RxNorm: atenolol
Sponsors & collaborators
University of Floridalead sponsor
GlaxoSmithKlinecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00669279 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.